Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 2
1918 1
1937 1
1938 1
1939 1
1948 4
1954 1
1956 1
1957 2
1958 3
1959 1
1960 1
1961 2
1962 3
1963 3
1964 10
1965 5
1966 2
1967 5
1968 9
1969 4
1970 8
1971 8
1972 11
1973 11
1974 12
1975 15
1976 24
1977 31
1978 26
1979 31
1980 36
1981 28
1982 33
1983 42
1984 38
1985 42
1986 27
1987 35
1988 42
1989 55
1990 54
1991 63
1992 61
1993 41
1994 46
1995 59
1996 73
1997 64
1998 60
1999 66
2000 69
2001 78
2002 73
2003 88
2004 103
2005 129
2006 156
2007 149
2008 191
2009 272
2010 265
2011 367
2012 350
2013 419
2014 519
2015 533
2016 554
2017 699
2018 789
2019 868
2020 1166
2021 1479
2022 1605
2023 1615
2024 612

Text availability

Article attribute

Article type

Publication date

Search Results

12,850 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Missaui
Page 1
Did you mean Ali M. missaoui (6 results)?
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Burris HA 3rd, Okusaka T, Vogel A, Lee MA, Takahashi H, Breder V, Blanc JF, Li J, Bachini M, Żotkiewicz M, Abraham J, Patel N, Wang J, Ali M, Rokutanda N, Cohen G, Oh DY. Burris HA 3rd, et al. Among authors: ali m. Lancet Oncol. 2024 May;25(5):626-635. doi: 10.1016/S1470-2045(24)00082-2. Lancet Oncol. 2024. PMID: 38697156 Clinical Trial.
Survival after Trastuzumab Therapy in Patients with Locally Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of Randomized Controlled Trials.
Ali MD, Al-Matouq JA, Ahmad A, Patel M, Alshnbari AS, Alhussini SH, Almozien SF, Alowaywi GA, Kannan LS. Ali MD, et al. J Pharm Bioallied Sci. 2024 Jan-Mar;16(1):24-30. doi: 10.4103/jpbs.jpbs_563_23. Epub 2024 Mar 21. J Pharm Bioallied Sci. 2024. PMID: 38694962 Free PMC article.
12,850 results
You have reached the last available page of results. Please see the User Guide for more information.